Recent strategies of carbon dot-based nanodrugs for enhanced emerging antitumor modalities

Xu Chu1, Mengdie Duan2, Huaying Hou2

  • 1State Key Laboratory of Separation Membranes and Membrane Processes, School of Materials Science and Engineering & School of Chemistry, Tiangong University, Tianjin 300387, P. R. China. yiliuchem@whu.edu.cn.

PubMed

Insights

Carbon dots enhance emerging cancer therapies by overcoming tumor barriers. This review explores carbon dot nanoplatforms for improved nanomaterial-based cancer treatment and clinical translation.

Area of Science:

  • Biomedical Engineering
  • Materials Science
  • Oncology

Background:

  • Nanomaterial-based cancer therapy offers advantages over traditional treatments.
  • Tumor microenvironments and self-protective mechanisms impede the efficacy of novel antitumor modalities.
  • Carbon dots are promising nanomaterials for biomedical applications due to their properties.

Purpose of the Study:

  • To review emerging therapeutic modalities for cancer.
  • To summarize advances in carbon dot-based nanoplatforms for enhancing antitumor effects.
  • To discuss the clinical translation prospects of carbon dot nanoplatforms in tumor therapy.

Main Methods:

  • Literature review of emerging cancer therapies.
  • Systematic summary of carbon dot applications in overcoming therapeutic barriers.
  • Analysis of clinical translation challenges and opportunities.

Main Results:

  • Carbon dots act as multifunctional nanoplatforms to improve therapeutic efficacy.
  • Carbon dots address limitations posed by tumor microenvironments and resistance mechanisms.
  • Recent advances demonstrate the potential of carbon dots in various emerging therapies.

Conclusions:

  • Carbon dot nanoplatforms show significant promise for enhancing emerging cancer therapies.
  • Further research is needed to address obstacles for clinical translation.
  • This review provides a reference for designing nanomaterials to improve tumor therapy efficacy.

Related Concept Videos